Literature DB >> 19091459

p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway.

N V Khromova1, P B Kopnin, E V Stepanova, L S Agapova, B P Kopnin.   

Abstract

The function of p53 tumor suppressor is often altered in various human tumors predominantly through missense-mutations resulting in accumulation of mutant proteins. We revealed that expression of p53 proteins with amino-acid substitutions at codons 175 (R175H), 248 (R248W), and 273 (R273H), representing the hot-spots of mutations in various human tumors, increased the number of vessels in HCT116 human colon carcinoma xenografts and, as a result, accelerated their growth. Stimulation of tumor angiogenesis was connected with about 2-fold increase in intracellular level of reactive oxygen species (ROS). Antioxidant N-acetyl-l-aspartate (NAC) decreased vessels number in tumors formed by cells with inactivated p53 and inhibited their growth. Effect of ROS on angiogenesis in tumors expressing hot-spot p53 mutants was correlated with their ability to increase a content of HIF1 transcriptional factor responsible for up-regulation of VEGF-A mRNAs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091459     DOI: 10.1016/j.canlet.2008.10.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

Review 1.  Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.

Authors:  Abigail Hielscher; Sharon Gerecht
Journal:  Free Radic Biol Med       Date:  2014-10-22       Impact factor: 7.376

Review 2.  Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

Authors:  Ruoji Zhou; An Xu; Julian Gingold; Louise C Strong; Ruiying Zhao; Dung-Fang Lee
Journal:  Trends Pharmacol Sci       Date:  2017-08-14       Impact factor: 14.819

3.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

Review 4.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma.

Authors:  Nilay Sethi; Osamu Kikuchi; James McFarland; Yanxi Zhang; Max Chung; Nicholas Kafker; Mirazul Islam; Benjamin Lampson; Abhishek Chakraborty; William G Kaelin; Adam J Bass
Journal:  JCI Insight       Date:  2019-08-08

Review 6.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

7.  E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth.

Authors:  M Farmakovskaya; N Khromova; V Rybko; V Dugina; B Kopnin; P Kopnin
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  Upregulation of HIF-1α via activation of ERK and PI3K pathway mediated protective response to microwave-induced mitochondrial injury in neuron-like cells.

Authors:  Li Zhao; Yue-Feng Yang; Ya-Bing Gao; Shui-Ming Wang; Li-Feng Wang; Hong-Yan Zuo; Ji Dong; Xin-Ping Xu; Zhen-Tao Su; Hong-Mei Zhou; Ling-Ling Zhu; Rui-Yun Peng
Journal:  Mol Neurobiol       Date:  2014-03-14       Impact factor: 5.590

9.  Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients group.

Authors:  Beata Biesaga; Joanna Niemiec; Marek Ziobro
Journal:  Pathol Oncol Res       Date:  2012-05-02       Impact factor: 3.201

10.  Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs.

Authors:  Simon Leuchs; Anja Saalfrank; Claudia Merkl; Tatiana Flisikowska; Marlene Edlinger; Marina Durkovic; Nousin Rezaei; Mayuko Kurome; Valeri Zakhartchenko; Barbara Kessler; Krzysztof Flisikowski; Alexander Kind; Eckhard Wolf; Angelika Schnieke
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.